Treatment simplification to optimize cenobamate effectiveness and tolerability: A real‐world retrospective study in Spain

Autor: Juan Jesús Rodríguez‐Uranga, Juan María Sánchez‐Caro, Roshan Hariramani Ramchandani

Publikováno v: Epilepsia Open, Vol 9, Iss 4, Pp 1345-1356 (2024)

Abstract Objective This study aimed to explore the impact of co‐antiseizure medication (co‐ASM) optimization on the effectiveness and tolerability of adjunctive cenobamate (CNB) in patients with drug‐resistant epilepsy in a real‐world setting

Externí odkaz: https://doaj.org/article/ee6ccf9879c2430abdc141dd966533b4

Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug‐resistant focal seizures

Autor: Mar Carreño, Antonio Gil‐Nagel, José M. Serratosa, Manuel Toledo, Juan Jesus Rodriguez‐Uranga, Vicente Villanueva

Publikováno v: Epilepsia Open, Vol 9, Iss 3, Pp 1051-1058 (2024)

Abstract Objective Cenobamate is an antiseizure medication (ASM) associated with high rates of seizure freedom and acceptable tolerability in patients with focal seizures. To achieve the optimal cenobamate dose for maximal potential effectiveness whi

Externí odkaz: https://doaj.org/article/a918501ee9b846fbb730989b8c291bc6

Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)

Autor: Hernando Pérez Díaz, N. Peláez, Guillermina García Martín, L. Redondo, Óscar Vega López, Francisco Vázquez, Javier Abril Jaramillo, Elena Vila Herrero, C. De la Fuente, Juan Miguel Girón Úbeda, Juan Jesús Rodríguez Uranga, José Carlos Estévez María, María Elena Calzado Rivas, M. Chamorro-Muñoz, Patricia Santágueda

Publikováno v: Epilepsy & Behavior. 102:106655

Objective Perampanel (PER) has been shown to be effective as an adjunctive therapy for controlling refractory focal-onset seizures (FOS). However, the information as early add-on for the treatment of FOS in the clinical practice is still scarce and m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3f6bc0a8fbe7aac76af420ae4cfbad
https://doi.org/10.1016/j.yebeh.2019.106655

EPILEPSY SURGERY IN DRUG RESISTANT TEMPORAL LOBE EPILEPSY ASSOCIATED WITH NEURONAL ANTIBODIES

Autor: Francesc Graus, Tim Wehner, Martin Elisak, Eva Baillés, Jordi Rumià, Francisco Gil, Vicente Villanueva, Javier Aparicio, Rajiv Mohanraj, Christian G. Bien, José Pimentel, Juan Jesús Rodríguez Uranga, Petr Marusic, Antonio Donaire, Núria Bargalló, Josep Dalmau, Teresa Boget, Mar Carreño, Asier Gómez-Ibáñez, Michael R. Sperling, Ali A. Asadi-Pooya, Mercè Falip, Pedro Roldán, Xavier Setoain, Luis Pintor

Publikováno v: Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Carreño, M, Bien, CG, Asadi-Pooya, AA, Sperling, M, Marusic, P, Elisak, M, Pimentel, J, Wehner, T, Mohanraj, R, Uranga, J, Gómez-Ibáñez, A, Villanueva, V, Gil, F & Graus, F 2016, ' Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies. ', Epilepsy Research . https://doi.org/10.1016/j.eplepsyres.2016.12.010
EPILEPSY RESEARCH
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

We assessed the outcome of patients with drug resistant epilepsy and neuronal antibodies who underwent epilepsy surgery. Retrospective study, information collected with a questionnaire sent to epilepsy surgery centers. Thirteen patients identified, w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674eaa14e33c312d401a090618bd3fbf
https://europepmc.org/articles/PMC5285301/

Tratamiento combinado con fármacos antiepilépticos. Guía Andaluza de Epilepsia 2015

Autor: Juan Carlos Sánchez Álvarez, Julio Ramos Lizana, Irene Sofia Machado Casas, Pedro Jesús Serrano Castro, Jacinto Luis Martínez Antón, Jesús Ruiz Giménez, en representación del Comité Edit en representación del Comité Edit, María Aguilar Andújar, Olga Alonso Luengo, Carmen Arenas Cabrera, Mª. Luisa Arrabal Fernández, Bárbara Blanco Martínez, Heriberto Busquier Hernández, Manuel Caballero Martínez, Rafael Camino León, Francisco M. Cañadillas Hidalgo, María Isabel Chamorro Muñoz, Luminita Dinca Avarvarei, José Carlos Estévez Marías, Victoria Eugenia Fernández Sánchez, Javier Fernández Pérez, Juan M. Galán Barranco, Benito Galeano Bilbao, Alberto Galdón Castillo, Esther Gallardo Corral, Natalia García Casares, Guillermina García Martín, Francisco Gascón Giménez, Manuel Gómez Ríos, Antonio Gutiérrez Cardo, Javier Gutiérrez García, Francisco J. Hernández Ramos, Eduardo López Laso, Antonio Maldonado Contreras, Paula Martínez Agredano, Gema Martínez Espinosa, Manuel Martínez Grueiro, Carlos Martínez Quesada, Juan María Mercadé Cerdá, Rafael Merino de Torres, Antonio Molina Carballo, Amparo Montalvo Valdivieso, María Dolores Morales Martínez, Manuel Nieto Barrera, Gonzalo Olivares Granados, Manuel Payán Ortiz, Pablo Quiroga Subirana, Luis Redondo Vergé, M. Concepción Robles Vizcaino, Juan Jesús Rodríguez Uranga, Susana Roldán Aparicio, Jorge Romero Godoy, Miguel Rufo Campos, Carlos Sánchez Corral, Iván Sladogna Barrios, Francisco Villalobos Chaves

Publikováno v: Revista de Neurología. 60:365

Objetivo. Elaborar unas recomendaciones basadas en evidencias cientificas y en consenso de los autores y revisores, que aborden las cuestiones basicas acerca de la combinacion de farmacos antiepilepticos. Desarrollo. Un comite de 11 expertos pertenec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::45ce997e04735d5413d042d92058c4f2
https://doi.org/10.33588/rn.6008.2014528